Showing 191-200 of 354 grants

Title Institution Researcher Program Duration Total Award Amount
EFFICACY AND SAFETY OF ONCE WEEKLY SEMAGLUTIDE IN ADULTS WITH OBESITY AND INADEQUATELY CONTROLLED TYPE 1 DIABETES USING HYBRID CLOSED-LOOP SYSTEM Regents of the University of Colorado Janet Snell-Bergeon Improving Lives 01-November-2022 to 31-October-2027 $2,282,771.83
Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes Regents of the University of Colorado Jessica Kendrick Improving Lives 01-October-2022 to 31-October-2027 $899,235.00
Investigating the association between environmental contaminants and progression to autoimmune disease Regents of the University of Colorado Jill Norris Cures 01-September-2026 to 31-August-2027 $149,999.97
Islet autoantibody concordance and metabolic monitoring of individuals identified at risk for type 1 diabetes through population-based screening Regents of the University of Colorado Kimber Simmons Cures 01-July-2023 to 31-December-2026 $750,000.00
Innovating Methods for AssessinG INsulin Action in Type ONe diabetes (IMAGINATiON) Regents of the University of Colorado Kristen Nadeau Improving Lives 01-December-2021 to 31-December-2026 $445,816.29
Validation of Enzyme-linked immunosorbent assay (ELISA) to detect insulin autoantibodies Regents of the University of Colorado Liping Yu Cures 01-June-2025 to 31-May-2027 $453,852.00
Antigenic Targets of CD4 T cells across the stages of type 1 diabetes Regents of the University of Colorado Maki Nakayama Cures 01-August-2022 to 31-July-2026 $749,998.87
Autoimmunity Screening for Kids (ASK) Regents of the University of Colorado Marian Rewers Cures 01-November-2024 to 31-October-2027 $3,074,807.75
Immunogenicity of workload-regulated beta cell states in type 1 diabetes Regents of the University of Colorado Matthew Wortham Cures 01-August-2026 to 31-July-2031 $1,000,000.00
Mechanisms of B Cell Polyreactivity in Autoimmunity: Toward Precision Immunotherapy Regents of the University of Colorado Mia Smith Cures 01-September-2025 to 31-January-2027 $149,965.60